文献速递炎症性肠病消化内镜

克罗恩病患者原发性回结肠狭窄的内镜下球囊扩张与手术切除的结局比较

Outcomes of Endoscopic Balloon Dilation vs Surgical Resection for Primary Ileocolic Strictures in Patients With Crohn's Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-03-02

这项回顾性研究比较了258例原发性狭窄型回结肠克罗恩病患者(初始内镜下球囊扩张117例、回结肠切除258例)的术后并发症和无手术生存率,发现球囊扩张初期成功且不良事件少,但挽救手术率高;初始回结肠切除术后不良事件更多,但再次手术需求更少、无手术生存期更长。

要点

  • 内镜下球囊扩张后并发症发生率4.7%,44.4%的患者需要挽救手术。
  • 回结肠切除组术后不良事件更常见(32.2%),但二次手术需求更低(21.7%)。
  • 回结肠切除组无手术生存期显著更长(11.1±0.6年 vs 5.4±0.6年)。

核心结论

  • 在这项回顾性研究中,内镜下球囊扩张初期成功且不良事件少,但挽救手术频率高;初始回结肠切除与更高的并发症发生率相关,但无手术间期更长。
  • 选择个体患者的治疗时应权衡风险与获益。

研究设计与样本

  • 回顾性研究,比较2000年至2016年间258例原发性狭窄型回结肠克罗恩病(B2、L1或L3)患者初始接受内镜下球囊扩张(n=117)或回结肠切除(n=258)的术后并发症和无手术生存率。
  • 排除穿透性疾病患者,采用多因素分析评估与无手术生存相关的因素。

主要发现

  • 内镜下球囊扩张后并发症发生率为4.7%,44.4%的患者需要挽救手术。
  • 内镜下球囊扩张组中与无手术生存降低相关的因素包括狭窄长度增加(风险比2.0;95%CI 1.3-3.3)、回结肠病变 vs 回肠病变(风险比10.9;95%CI 2.6-45.4)以及内镜下球囊扩张操作间隔缩短(风险比1.2;95%CI 1.1-1.4)。
  • 内镜下球囊扩张组与回结肠切除组在性别、年龄、种族或克罗恩病病程方面无显著差异。
  • 回结肠切除组术后不良事件更常见(32.2%;P < .0001),但二次手术需求更低(21.7%;P < .0001),无手术生存期显著更长(11.1±0.6年 vs 5.4±0.6年;P < .001)。

临床怎么用

  • 原文未据此给出推荐,作者认为选择个体患者的治疗时应权衡风险与获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Few studies have compared endoscopic balloon dilation (EBD) with ileocolic resection (ICR) in the treatment of primary ileocolic strictures in patients with Crohn's disease (CD). METHODS: We performed a retrospective study to compare postprocedure morbidity and surgery-free survival among 258 patients with primary stricturing ileo(colic) CD (B2, L1, or L3) initially treated with primary EBD (n = 117) or ICR (n = 258) from 2000 through 2016. Patients with penetrating disease were excluded from the study. We performed multivariate analyses to evaluate factors associated with surgery-free survival. RESULTS: Postprocedural complications occurred in 4.7% of patients treated with EBD and salvage surgery was required in 44.4% of patients. Factors associated with reduced surgery-free survival among patients who underwent EBD included increased stricture length (hazard ratio, 2.0; 95% CI, 1.3-3.3), ileocolonic vs ileal disease (hazard ratio, 10.9; 95% CI, 2.6-45.4), and decreased interval between EBD procedures (hazard ratio, 1.2; 95% CI, 1.1-1.4). There were no significant differences in sex, age, race, or CD duration between EBD and ICR groups. Patients treated with ICR were associated with more common postoperative adverse events (32.2%; P < .0001), but a reduced need for secondary surgery (21.7%; P < .0001) and significantly longer surgery-free survival (11.1 ± 0.6 vs 5.4 ± 0.6 y; P < .001). CONCLUSIONS: In this retrospective study, we found that although EBD is initially successful with minimal adverse events, there is a high frequency of salvage surgery. Initial ICR is associated with a higher morbidity but a longer surgery-free interval. The risks and benefits should be balanced in selecting treatments for individual patients.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lan N, Stocchi L, Ashburn JH, et al. Outcomes of Endoscopic Balloon Dilation vs Surgical Resection for Primary Ileocolic Strictures in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2018. PMID: 29505909. doi:10.1016/j.cgh.2018.02.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。